Epinephrine-induced Insulin Resistance in Man
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Abstract
Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.
Overview
CoChat Summary
TL;DR
In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.
Key findings
- During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
- Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
- Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
- Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.
Methods
- Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
- Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
- Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.
Limitations
- Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
- Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an in vivo effect of epinephrine on peripheral glucose metabolism independent of changes in plasma insulin levels has not been conclusively documnented.”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Disputedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
The Discussion reports that epinephrine reduced glucose clearance in conscious dogs despite a two- to fourfold rise in plasma insulin, and concludes that the effect was not mediated primarily by suppressed insulin secretion. This is contrary to the claim that an in vivo peripheral effect had not been documented independently of changes in insulin levels, although the paper does not claim to have excluded every contribution from insulin secretion. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies have documented that epinephrine inhibits insulin secretion (1–5)”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Partly supportedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
On p. 120, the paper says epinephrine subsequently inhibits insulin release in dogs. It also reports an initial twofold rise in plasma insulin and describes the effect as biphasic, so the unqualified claim omits an important timing qualification. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [3] 3. Altszuler, N., R. Steele, I. Rathgeb, and R. C. DeBodo. 1967. Glucose metabolism and plasma insulin levels during epinephrine infusion in the dog. Am. J. Physiol. 212(3): 677–682. source
- Supportedcites [4] 4. Coore, H. G., and P. J. Randle. 1964. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93: 66–78. source
The Results report that adrenaline (epinephrine) abolished the stimulation of insulin release by high glucose in rabbit pancreas pieces incubated in vitro. The Discussion identifies this inhibitory effect as a major finding. The paper also notes that adrenaline had no effect at low glucose; the citing sentence does not claim inhibition under every condition. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [5] 5. Porte, D. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86–94. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During both clamp studies in which propranolol was infused, the decline in plasma glucagon was similar to the control insulin clamp study (P < 0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After insulin alone, hepatic glucose production declined by 92% to 0.16±0.08 mg/kg·min.”
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During insulin administration alone, glucose metabolism averaged 5.49±0.58 mg/kg·min.”
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased sympathovagal balance also adds to insulin resistance131”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1210/jcem-50-2-294 · retracted 1980-11-01 · notice 10.1210/jcem-51-5-1201 · this paper published 1980-03-01
Citations
Cites
1 retracted
Soman, V., Shamoon, H., Sherwin, R. S., & Ziegler, W. H. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-294 · Cited by 22
RetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Exton, J. H., Robison, G. A., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61771-5 · Cited by 320
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationChristensen, N. J. (1974) · Diabetes · doi:10.2337/diab.23.1.1 · Cited by 287
Mechanism of Plasma Catecholamine Increases During Surgical Stress in Man
HALTER, J. B., PFLUG, A. E., & PORTE, D. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-936 · Cited by 279
Control of Gluconeogenesis in Liver
Exton, J. H., & Park, C. R. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93242-4 · Cited by 278
Cited by
Items 501–556 of 556
Gans, R. O. B., & Donker, A. J. M. (1996) · Springer eBooks · doi:10.1007/978-1-4757-6749-0_29
The Regulation of Net Hepatic Glucose Uptake in vivo
DiCostanzo, C. A. (2005) · Europe PMC (PubMed Central)
Die kardiopulmonale Reanimation bei Kindern
Engelbarts, M. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12916
Vicini, P., Avogaro, A., Spilker, M. E., Gallo, A., & Cobelli, C. (2016)
Physiologic Changes Associated with Bed Rest and Major Body Injury
Downey, R. J., & Weissman, C. (1994) · Elsevier eBooks · doi:10.1016/b978-1-4831-7818-9.50023-x
Intolerance in Normal Humans ROLE OF THE SPLANCHNIC BED
Saccà, L., Vigorito, C., Cicala, M., Ungaro, B., & Sherwin, R. S. (1982)
Mechanismen der Insulinresistenz
Holtz, J. (1993) · Springer eBooks · doi:10.1007/978-3-642-47621-1_1
-Insulin sensitivity, AT-1 receptor blockade and sympathetic activity
Aksnes, T. A. (2008)
Central Nervous System (CNS) Nutrient Sensing in Diabetes
Chari, M. (2010) · TSpace (University of Toronto)
Venkatesh, D. K., Raghuram, D. C., & kumar, D. A. R. (2016) · International Journal of Advanced Research · doi:10.21474/ijar01/2524
Short Communications Insulin Effect in Chronic Alcoholics During Alcohol Withdrawal
Adner, N., & Nygren, A. (1982)
Conde, F. G. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128321
Guelfi, K. J. (2006) · UWA Profiles and Research Repository (UWA)
Metabolic Regulation by Stress Mediators in Fetal Ovine Skeletal Muscle and Adult Bovine Myoblasts
Merrick, E. M. (2017) · Lincoln (University of Nebraska)
Earl, L. R. (2011) · Louisiana State University · doi:10.31390/gradschool_theses.4144
“Furthermore, even with persistent hyperinsulinemia, epinephrine produced from stress can amplify glucose production from the liver (Deibert and Defronzo, 1980).”
InfluentialVaitkus, J. A., Smith, S. C., Boikos, S. A., & Celi, F. S. (2018) · AACE Clinical Case Reports · doi:10.4158/accr-2018-0072
Routine Glucose Monitoring in Postoperative Pheochromocytoma Patients: Yes or No?
Goel, N., & Lee, J. A. (2018) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-319-92860-9_28
ALTAIR versus Albarel: efficiency and tolerance in arterial hypertension
Shlyakhto, E. V., & Конради, А. О. (2004) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2004-10-3-163-164 · Cited by 1
Kerrigan, L. (2019) · doi:10.31390/gradschool_theses.4994
“results in impaired glucose tolerance due to epinephrine suppressing insulin secretion [67].”
BackgroundThe effect of lipids on glucoregulatory hormone actions
Grueter, E., & Alicia, C. (2006)
Endocrine Disorders that Cause Diabetes
Hanley, N. A. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch17 · Cited by 3
Akhter, M. S., Faruque, M., Rahman, M. T., Rahman, M. A., Mohiuddin, M. A. K., & Islam, S. Z. (2020) · Bangladesh Heart Journal · doi:10.3329/bhj.v35i1.49138
Exercise and Protein Metabolism
(2007) · Nutrition in exercise and sport · doi:10.1201/9781420043815.ch2
Evaluation of the Impact of Short Duration Music Listening on Autonomic State (Preprint)Preprint
Elvin, G., Patel, P., Sice, P. V., Riachy, C., Osborne, N., & Bentley, E. (2021) · doi:10.2196/preprints.26966
Semsroth, M. (1993) · Springer eBooks · doi:10.1007/978-3-642-97183-9_34
Evaluation of the Impact of Short Duration Music Listening on Autonomic State (Preprint)Preprint
Elvin, G., Patel, P., Sice, P. V., Riachy, C., Shang, Y., Osborne, N., Rauch, L., & Bentley, E. (2020) · doi:10.2196/preprints.22433
Solini, A., & DeFronzo, R. A. (1994) · Springer eBooks · doi:10.1007/978-1-4757-6746-9_4
Self-citationEpinephrine inhibits PI3K alpha via the Hippo kinasesPreprint
Lin, T.-Y., Ramsamooj, S., Liberatore, K. M., Lantier, L., Vasan, N., Karukurichi, K. R., Hwang, S., Kesicki, E. A., Kastenhuber, E. R., Wiederhold, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.19.500601
The evidence behind early aggressive multi-drug treatment in type 2 diabetes
Cersósimo, E., Solis‐Herrera, C., & Triplitt, C. L. (2021) · Trends in Diabetes and Metabolism · doi:10.15761/tdm.1000121 · Cited by 1
Li, M., Xiao, R., Chen, S., et al. (2022) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2022.3203
The Role of Sleep Apnea in Diabetes Mellitus and Cardiovascular Disease
Anand, A., Patel, J., & Pogach, M. S. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_11 · Cited by 1
Diabetes in Hypersecreting Endocrine Disorders
Vaag, A. A., Hanley, N. A., & Kistorp, C. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch22
de Tijuana, I. T., Gamboa, D., Campos-Hernández, P. J., & de Tijuana, I. T. (2024) · Revista Mexicana de Ingeniería Biomédica · doi:10.17488/rmib.45.1.2
Ushigome, E., Imai, D., Hamaguchi, M., Hashimoto, S., & Fukui, M. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14380
“Third, hematological laboratory data, such as in fl ammatory markers, vaccination, smoking history, and SARS-CoV-2 variant are factors associated with the severity of COVID-19 but are considered limitations in this study due to lack of data.”
InfluentialPhysiological Basis of Insomnia
Bonnet, M. H., & Arand, D. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-662-1_3 · Cited by 1
Regulation of Extramuscular Fuel Sources During Exercise
Wasserman, D. H., & Cherrington, A. D. (1995) · Comprehensive physiology · doi:10.1002/j.2040-4603.1995.tb01720.x · Cited by 1
Synthesis, Storage, and Secretion of Adrenal Medullary Hormones: Physiology and Pathophysiology
Young, J. B., & Landsberg, L. (2000) · Comprehensive physiology · doi:10.1002/j.2040-4603.2000.tb01506.x · Cited by 1
Richter, E. A. (1995) · Comprehensive physiology · doi:10.1002/j.2040-4603.1995.tb01717.x
Control of Glycolysis and Glycogen Metabolism
Connett, R. J., & Sahlin, K. (1995) · Comprehensive physiology · doi:10.1002/j.2040-4603.1995.tb01716.x · Cited by 1
DeFronzo, R. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70347 · Cited by 4
Self-citationGater, D. R. (1990) · UA Campus Repository (The University of Arizona)
The Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive physiology · doi:10.1002/j.2040-4603.2001.tb01481.x · Cited by 26
“The mechanisms of the plasma glucose-raising effect of epinephrine are complex (2, 9, 50, 51, 61, 83, 123, 166, 205, 207, 208, 219, 232).”
Zhou, Y., Lv, X., Liang, Y., Zheng, B., Zhang, Y., Wu, Q., Liu, G. X., & Lang, L. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6139145
Zhou, Y., Lv, X., Liang, Y., Zheng, B., Zhang, Y., Wu, Q., Liu, G. X., & Lang, L. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6139149
Yzydorczyk, C. (2011) · theses.fr (ABES) · doi:10.70675/79493b0fz49ecz4151zad3ezc0d9f2e5d333 · Cited by 1
“Cela pourrait s’expliquer par une augmentation de l’activité du système nerveux sympathique qui pourrait contribuer à la relâche de la noradrénaline [444] et de l’adrénaline [179] induisant une résistance à l’insuline dans le muscle squelettique.”
Song, S., Li, J., Chu, L., & 方向明 (2026) · BMC Surgery · doi:10.1186/s12893-026-03734-1
“Epinephrine promotes gluconeogenesis and glycogenolysis while inhibiting insulin secretion via β-adrenergic receptors [24].”
Zhou, Y., Lv, X., Liang, Y., Zheng, B., ZHANG, Y. H., Wu, Q., Liu, G. X., & Lang, L. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118131
Extrarenal potassium metabolism
Ahya, S. N., Gmurczyk, A., & Rosa, R. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-815389-5.00045-9
Okamura, M., Palus, S., Doehner, W., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13060241
“Elevated activity of the sympathetic nervous system may play a role in cachexia by boosting overall energy expenditure in the body and by having a direct toxic impact on skeletal muscle tissue [24–26]. β -blockers can attenuate these conditions associated with sympathetic hyperactivity [27,28].”
Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions
Lakshmi, N., Mohan, A. R., Ali, H., Adamkiewicz, G., Rajendra, P., Al‐Mulla, F., Mohan, V., & Alahmad, B. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01634-5
“These hormones stimulate hepatic glucose production and worsen insulin resistance and promote lipolysis and ketogenesis, thereby increasing the risk of diabetic ketoacidosis [30, 31].”
Wen, W., He, R., Fang, Z., Fang, S., & Zheng, L. (2026) · Medicine · doi:10.1097/md.0000000000050204
“[46] There is growing recognition that OSA is associated with chronic, low-grade systemic inflammation.”
Rodzeń, Ł., Rodzeń, M., Dyńka, D., Łojko, D., Karakuła‐Juchnowicz, H., Kraszewski, S., Fazio, S., Unwin, D., & Bikman, B. T. (2026) · Nutrients · doi:10.3390/nu18162666
“%) and the liver [35].”
The Interaction of Exercise, Stress, and Inflammation on Growth
Peckett, A. J., Timmons, B. W., & Riddell, M. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1795-9_145
Insulin Resistance and Experimental Hypertension
Galipeau, D., & McNeill, J. H. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4419-9232-1_20
“Studies have demonstrated that stimulation of s-adrenergic receptors can cause acute insulin resis tance [ 35 ] and an increase in the ratio of insulin resistant fast-twitch/slow-twitch fibers in skeletal muscle [36].”
Background
Metadata
- Authors
- Deibert, D. C., & Defronzo, R. A.
- Affiliations
- Yale University (US)
- ORCID
- Defronzo, Ralph A.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 717-721
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371414
- OpenAlex
- W2064971980
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
- MeSH terms
- Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.